Personalised home hazard assessments and interventions will help to prevent older and at-risk people from suffering from falls, according to new NICE guideline ...

Draft guidance issued for consultation recommends two technologies to help people manage their condition. A digital therapy that could reduce the severity of the symptoms of chronic tic disorders and ...

We know that AI is vital for the NHS to deliver reduced waiting times and faster diagnoses for patients, which is why the health service plays such a vital role in supporting technologies like DERM by ...

We're pleased to recommend linzagolix as a new treatment option for endometriosis. As a once-daily tablet taken at home, it offers a convenient way for people with endometriosis to manage their ...

There is a commercial access agreement for osimertinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

There is a simple discount patient access scheme for brentuximab vedotin. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Osimertinib with pemetrexed and platinum-based chemotherapy (Tagrisso) is available on the NHS as a possible treatment for advanced non-small-cell lung cancer that has not been treated before. It is ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

This guideline covers assessing risk of falling and interventions to prevent falls in all people aged 65 and over, and people aged 50 to 64 who are at higher risk of falls. It aims to reduce the risk ...

The following considerations around implementing the evidence generation process have been identified through working with system partners: ...

Brentuximab vedotin (Adcetris) with doxorubicin, dacarbazine and vinblastine is available on the NHS. It is a possible treatment for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma in adults.